NCT07898384
Optimizing Care Transitions in CHD
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Start date changed from estimate of Sep 2026 to Nov 3, 2026
- Site details revised
- Collaborators: 1 to 9
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (12)
Show 7 moreShow less
Arms and interventions
In addition to their standard medical care, mentees in the experimental group will receive mentorship and support via the iP2P/iParent2Parent program. Trained mentors will provide information and support to mentee participants to encourage participation in self-management skill-building tailored to their needs. Each mentor will work with no more than two mentees at once for the study. Efforts will be made to pair mentors and mentees who share similar characteristics (e.g., similar disease severity, symptom profile, treatment regimen experiences, caregiver role, sex/gender, geographic area of residence). To ensure safety, a member of the research team will monitor all calls and messaging conversations as well as intervene in any potential safety concerns (e.g., discussion of suicidal ideation) or inappropriate behavior (e.g. bullying).
The control group will receive standard care without the iP2P/iParent2Parent intervention. The control group will be offered the iP2P/iParent2Parent intervention after completion of all outcome measures for a period of 12 weeks with the same research team support.
Behavioral: Peer mentorship
Sites
1 site in 1 country
- The Hospital for Sick ChildrenToronto, Ontario, Canada